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Abstract15
The durability of host resistance is challenged by the ability of pathogens to16
escape the defense systems of their hosts. Understanding the variability in the17
durability of host resistance is of paramount importance for designing more effective18
control strategies against infectious diseases. Here we study the durability of various19
CRISPR-Cas alleles of the bacteria Streptococcus thermophilus against lytic phages.20
We found substantial variability in durability among different resistant bacteria.21
Since the escape of the phage is driven by a mutation in the phage sequence targeted22
by CRISPR-Cas, we explored the fitness costs associated with these escape mutations.23
We found that, on average, escape mutations decrease the fitness of the phage. Yet,24
the magnitude of this fitness cost does not predict the durability of CRISPR-Cas25
immunity. We contend that this variability in the durability of resistance may be due26
to variations in phage mutation rate or in the proportion of lethal mutations across27
the phage genome. These results have important implications for the understanding28
of the coevolution between bacteria and phages and for the optimal deployment29
of resistance strategies against pathogens and pests. In a broader perspective,30
understanding the durability of CRISPR-Cas immunity may also help develop more31
effective gene-drive strategies based on CRISPR-Cas9 technology.32
Introduction33
Public health and agriculture are constantly challenged by the spread of infectious diseases.34
An arsenal of various prophylactic and therapeutic strategies has been developed to limit35
the circulation of pathogens (e.g. introgression of resistance genes in plant varieties, use of36
antimicrobial drugs). Yet, the efficacy of those interventions can be rapidly eroded by the37
evolution of pathogen populations [1, 2, 3, 4]. It is important to note that distinct defense38
strategies may lead to very different evolutionary outcomes. For instance, imperfect39
immunity is known to select for more aggressiveness and virulence in pathogens [5, 6].40
In addition, distinct defense strategies may differ in their level of durability. Why are41
some host defense strategies overcome very rapidly while others remain effective for a42
long period of time [4, 7, 8]? A better understanding of the durability of host defenses43
(defined as the inverse of the speed of pathogen adaptation to those defenses) is key for44
the development of sustainable management strategies of pathogens and pests [7, 9].45
46
Empirical and experimental studies in plant pathosystems have played key roles in the47
identification of major factors acting on the durability of host resistance [4, 7, 9, 10, 11].48
For instance, the type of plant resistance is known to have a significant impact on the49
speed of pathogen adaptation. Qualitative resistance, an all-or-nothing response, is often50
considered to be less durable than quantitative resistance, which reduces disease progres-51
sion in the plant. This effect is usually attributed to the simpler genetic determinism52
of pathogen adaptation to qualitative resistance which involves a few (or even a single)53
major virulence genes [12]. In contrast, adaptation to the polygenic determinism of54
quantitative resistance requires multiple pathogen mutations [13, 14]. Yet, qualitative55
resistance exhibits much variation in durability [4]. A classical explanation for this56
variation in durability involves selective constraints acting on the pathogen population.57
More specifically, host defense is likely to be more durable if the mutations (virulence58
alleles) that allow the pathogen to escape qualitative resistance are associated with fitness59
costs [4, 12]. Understanding the selective constraints acting on the sites targeted by60
different resistance mechanisms may help predict the durability of resistance and limit the61
speed of pathogen adaptation [4, 15]. Testing this hypothesis, however, is often difficult62
in plant pathosystems where measuring the durability of specific resistance mechanisms63
in controlled experiments raises practical difficulties [16, 17].64
65
2
Here we use the interaction between bacteria and their lytic bacteriophages (or phages)66
to study the factors that modulate the durability of host resistance. Bacteria have access67
to a wide range of defense systems to defend themselves against phages [18, 19, 20, 21].68
Among these distinct defense systems, CRISPR–Cas (Clustered Regularly Interspaced69
Short Palindromic Repeats – CRISPR Associated Genes) has the unique ability to70
generate hundreds of different alleles of resistance targeting different sites in the phage71
genome [22]. Here, we exploit this unique property to explore the variability in durability72
among distinct CRISPR–Cas resistance alleles targeting the same phage. CRISPR-Cas73
is an adaptive prokaryotic immune defense which integrates into the CRISPR locus74
(integration of a spacer) a small phage-DNA sequence (the protospacer, here 30 bp75
long) from an invading genome and uses this memory to target and degrade subsequent76
invading matching DNA (interference) [23]. To select and integrate a specific protospacer77
from a foreign nucleic acid into its CRISPR array, many CRISPR–Cas systems rely on78
a 2-5 bp sequence, the PAM (Protospacer Adjacent Motif) [24], flanking one side of79
the protospacer sequence and mandatory for spacer integration and interference. Given80
its size, the PAM is present numerous times on the phage genome, leading potentially81
to hundreds of different resistances targeting various protospacers [22]. In this system,82
phages can only escape CRISPR-Cas by mutating their PAM or seed sequence (ie. the83
proximal part of the protospacer) [25]. As such, CRISPR-Cas immunity corresponds to84
a very specific form of qualitative resistance. In the following, we first quantified the85
ability of a phage to escape a set of resistant bacteria, each of them having a distinct86
new spacer targeting a unique single protospacer site in the phage genome. Second, we87
isolated escape phage mutants on each of the resistant bacteria (e.g. each phage escape is88
mutated at a specific and different protospacer region) and we characterized their relative89
fitness during the infection of a population of phage-sensitive bacteria. This experimental90
protocol allowed us to discuss the potential link between the fitness effects of escape91
mutations in the phage and the durability of different resistance alleles in the bacteria.92
Materials and Methods93
Bacterial strains and phages94
The clonal bacterium Streptococcus thermophilus DGCC 7710 (WT) and its clonal virulent95
phage 2972 were obtained from the Félix d’Hérelle Reference Center for Bacterial Viruses96
(www.phage.ulaval.ca) [26]. Bacteria were grown in LM17 broth (M17 Oxoid (37 g/L)97
with 5g/L of lactose) and incubated at 40◦C. For phage amplification 10 mM of sterile98
CaCl2 were added to the broth. Using a standardized protocol described in [27], a culture99
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of S. thermophilus DGCC 7710 was challenged with the virulent phage 2972, and the100
surviving colonies/cells (BIMs, Bacteriophage Insensitive Mutants) were screened by PCR101
for expansion of their CRISPR array, followed by a 2% agarose electrophoresis. Primer102
sequences and PCR protocol can be found in supplementary information A. We confirmed103
that each BIM possesses a different spacer by Sanger sequencing the newly acquired104
spacer (Eurofins Genomics). A total of 17 different BIMs, each with a single and distinct105
spacer acquired into the active CRISPR1 locus of a type II-A CRISPR-Cas system,106
were kept and used in this study. Spacer sequences are provided in the supplementary107
information B. Finally, protospacers were positioned on the genome of phage 2972 that108
is published in [26].109
Phage detection and titration110
Bacterial lawns were produced by plating 6 mL of soft agar (LM17+CaCl2 with 0.8%111
agar and 400 µL of bacteria in mid-exponential phase) on top of plates previously poured112
with 30 mL of hard agar (LM17+CaCl2 with 1.5% agar). For phage titration, 50 µL of113
diluted phages were added to soft agar. For phage detection, 5 µL of phage solution were114
spotted directly on the solidified soft agar. When needed, phages were diluted in phage115
buffer (50 mM Tris-HCl pH7.5 + 100 mM NaCl + 8 mM MgSO4). Plates were incubated116
overnight at 40◦C and plaques were counted (titration) or recorded (detection).117
Durability of resistance118
How can we measure the durability of a resistance? The durability of a resistance is119
defined as the time between its introduction at a large scale and its large circumvention120
by parasite when conditions are favorable for the parasite development [7]. Consequently,121
in absence a pre-existing escape parasite, the durability of a resistance depends on two122
factors: 1) the rate at which escape mutants are generated and 2) their spread into the123
host population. In the case of an homogeneous resistant host population, any viable124
escape mutants will inevitably spread quickly into the population. Therefore, in this125
simple case, the durability of a resistance depends mainly on the rate at which viable126
escape mutants appears. When escape mutants can only appear by mutation, measuring127
their rate of apparition is the same as measuring the mutation rate of parasite targeted128
sequence, here the PAM and seed sequences.129
130
The viable mutation rate of a sequence can be measured using a Luria-Delbrück131
protocol. The durability of resistance of each of the 17 distincts BIM was measured132
using a three-steps Luria-Delbrück protocol (see supplemental informations C for a133
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graphic overview of the protocol). These measurements were replicated 3 times with 3134
independent clonal lysates of phage 2972. To ensure that pre-existing escape mutants135
have not altered these measurements, we measured for each BIM, the initial frequency of136
escape mutants. The frequency of pre-existing mutants to each of the 17 different BIMs137
was found to be below 2.9× 10−5. Because we inoculated a small quantity of phage 2972138
(see below), the impact of the standing genetic variance on the adaptation of the phage139
was assumed to be negligible.140
141
In the first step of this protocol, for each BIM, WT phages were amplified in 96 inde-142
pendent replicates on the WT-phage-sensitive bacteria (i.e. in the absence of selection).143
In each replicate, 20 µL of LM17+CaCl2 were inoculated with 0.2 µL of WT bacteria144
in mid-exponential phase, phages at a concentration of 300 PFU/20µL and incubated145
at 40◦C for 24 hours. We confirmed by titrating four replicates before incubation that146
Ni ≈ 300 PFU/20 µL and we measured Nf by titrating 10 randomly chosen lysates. We147
found Nf ≈ 1.72× 106 PFU/20 µL.148
149
In the second step of the protocol, the bacteria from each replicate were pelleted down150
with a 5-minute centrifugation (6189g) (see supplementary information D) and 25%151
(5µL) of the supernatant was inoculated into a 200 µL culture of the focal BIM and152
incubated for 24 hours at 40◦C. This second step ensured that even in replicates where153
the frequency of escape mutants was small at the end of the first step, the frequency of154
escape mutants would be sufficiently high to be detectable in the third step of the protocol.155
156
In the final and third step of the protocol, the presence of escape phages in each157
individual replicate was assessed using phage detection assays. PE , the probability of158
escape, was calculated as the fraction of replicates where phage escape was detectable. It159
is possible [28] to estimate the rate of escape mutations against each BIM using:160
µ = − ln (1− PE)
z(Nf −Ni)
with µ the mutation rate per target sequence (seed and PAM sequences), z the fraction161
of lysate used for the second amplification (here 1/4), Nf the final number of phages per162
replicate and Ni the initial number of phages per replicate. To further strenghten the163
results, the entire protocol has been triplicated with 3 independent clonal phage lysate.164
Therefore, for each BIM, the estimation of p comes from 288 independant lysates.165
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Relative fitness of phage escape mutants166
For each of the 17 different BIMs, we selected at random 5 phage isolates that escaped167
bacterial resistance. A single plaque from each of these 5 isolates was amplified in liquid168
and re-isolated twice on plates, on the BIM on which they were isolated from. After169
amplification, phages and remaining bacteria were separated by filtration (0.2 µm) and170
phages were stored in 20% glycerol at -80◦C. Genome sequencing (see supplementary171
information E for the list of primers and F for their protospacer sequence) confirmed172
that all escape phages contained mutations in their PAM or their seed sequence. This173
protocol generated a collection of escape mutants for all BIMs.174
175
The relative fitness of all the escape mutants was determined using triplicate competition176
experiments against a reference phage which contains a 37-bp deletion in its orf24177
(see supplemental information G). This deletion allowed us to readily distinguish the178
reference strain from all the other escape mutants (see section G in the supplementary179
information). Approximately 3 000 phages (50% escape mutant and 50% reference phage)180
were inoculated in 10 mL LM17+CaCl2 supplemented with 100 µL of WT bacteria in181
early stationary phase. After a 24 hour incubation at 40◦C, the remaining bacteria were182
removed by filtration and phages were stored at -80◦C. Before and after amplification, the183
proportion of the tested phage was measured by qPCR (see section G in the supplementary184
information). The relative fitness of the escape mutant m was determined using:185
sm = rm − rWT = log
(
pf (1− pi)
pi (1− pf )
)
− log
 p′f (1− p′i)
p′i
(
1− p′f
)

where rm and rWT refer to the malthusian growth rates of the escape mutant and the186
WT phage, respectively, pi and pf (respectively, p′i and p′f ) are the frequencies of the187
mutant phage before and after the competition (the prime refers to the frequency of the188
WT phage 2972).189
Statistical analyses190
All statistical analyses were run using R Software (version 3.3.2, [29]), through RStudio191
(Version 1.0.136). For mixed model, R package lme4 version 1.1-13 was used [30].192
193
We performed an Analysis of Variance (ANOVA) to determine if the position of the194
protospacer on the phage genome impacts the durability of resistances.195
Linear models were used for the analysis of relative fitness data. In the first model, we196
tested the effect of phage genotype on relative fitness. In the second model, we tested the197
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impact of mutation type (synonymous vs non-synonymous) on relative fitness of phages198
escaping the BIMs that target an orf (36 phage escape mutants). In the third model, we199
assessed the effect of the relative fitness of phage escape mutants on the durability of200
resistance of their respective BIM.201
Results202
To study the durability of various CRISPR alleles, we generated 17 different resistant203
strains (BIMs) characterized by a new and unique spacer within the CRISPR1 array.204
Each spacer targets a different protospacer, ie. a different part of the phage genome205
(supplemental data B). In total, 13 of the 44 phage genes (as well as some non-coding206
regions) were targeted by at least one spacer, leading to a good coverage of the phage207
genome by these 17 BIMs (Figure 1).208
209
Our measures of BIMs’ durability using fluctuation tests, revealed considerable vari-210
ation in the ability of the phage to escape different BIMs (Figure 1, supplementary211
information H, ANOVA, F-value = 10.89, df =16, p-value < 0.001). We also used the212
probability of escape to estimate the mutation rates for each target sequence (seed and213
PAM sequences) (see supplementary information I). The average mutation rate was214
estimated to be 3.4× 10−7 mutation/target sequence/replication and the escape rate of215
the less durable BIM was 123 times higher than the one of the most durable BIM.216
217
One possible explanation for the observed variation in durability of resistances is that218
there are differences in the fitness costs associated with these different escape mutations.219
Indeed, the Luria-Delbrück protocol used to measure the durability of resistances assume220
that phage escape mutations are neutral [31]. This assumption is unlikely to be met221
here and an heterogeneity in the fitness of the escape phage could explain the observed222
heterogeneity in durability. To explore this hypothesis, we isolated 40 phage mutants223
escaping the 17 distinct single CRISPR-resistances. A total of 35 escape phages carry224
a single bp mutation in the targeted sequence, 4 of the remaining phages carry double225
bp mutations in the targeted sequence, one escape phage has a single bp deletion (see226
supplementary information F). Among the substitutions, 27 are transversions, 12 are227
purine transitions and 4 pyrimidine transitions. Ten escape mutants were characterized228
by synonymous mutations (see supplementary information J).229
230
To measure fitness, we competed each of the escape phage mutants against a reference231
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phage and measure their relative abondance before and after the experiment. From these232
data, we deduce relative fitness. We found that relative fitness was highly variable, ranging233
from -6.21 to 0.68 with an average of -2.22 and a standard deviation of 1.71 (Figure 2,234
see supplementary information K). Although the majority of the phage escape mutants235
had a lower fitness than the WT phage (32/40), some escape mutants were neutral (8/40)236
(Figure 2, supplementary information K). The presence of non-synonymous mutations237
was not a good predictor of escape mutant fitness (t-value = -0.509, P(R>t) = 0.612)238
and all tested synonymous mutations but one lower phage fitness (see supplementary239
information L). Interestingly, we also found that escape mutant fitness was not a good240
predictor of the durability of each BIM (Figure 3, t-value = -0.423, P(R>t) = 0.673).241
Hence, the heterogeneity in the durability of CRISPR resistances is not caused by the242
heterogeneity of fitness costs associated with these escape mutations (see Figure 3).243
Discussion244
We studied the variation in the ability of the virulent phage 2972 to escape distinct resis-245
tance alleles at the CRISPR-Cas immune system of its host S. thermophilus DGCC7710.246
We found i) considerable variation in the durability among these different resistant strains247
(and therefore in the apparent mutation rate of phage protospacers) and ii) substantial248
variation in fitness among phages carrying escape mutations. Yet, the cost of those escape249
mutations was not associated with the durability of their respective resistance strains.250
If the fitness cost of escape mutations is not a good predictor of resistance durability251
what drives the variation in durability? We believe that two non-mutually exclusive252
processes could explain the observed patterns: (i) variation in the mutation rate along253
the phage genome and (ii) variation in the probability of generating lethal mutations254
among different sequences targeted by the CRISPR-Cas system.255
256
First, a variation in the mutation rate along the phage genome can result from an het-257
erogeneity of the replication machinery. Such a variation in mutation rates has previously258
been described in yeast [32], RNA viruses [33] and bacteria [34] but to our knowledge259
not yet in bacteriophages. The precise mechanism used by phage 2972 to replicate and260
repair its genome is unknown, limiting our ability to test this hypothesis. However, since261
phage 2972 encodes and expresses its own replication machinery and does not possess262
any repair mechanism [26, 35], it is tempting to hypothesize that no repair mechanisms263
are involved and that the entire replication is made by its replication machinery. This264
machinery could yield substantial variation among different parts of the phage genome.265
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Note, however, that most escape mutants we isolated were due to transversions instead266
of transitions (see supplementary information J), whereas most replication machineries267
show a biased pattern to transition [32, 36]. If a heterogeneous fidelity rate was at the268
origin of the observed heterogeneity in durability of resistances, 2972 machinery would269
have an unconventional mutation bias.270
271
Second, variation in the frequency of lethal mutations along the phage genome could272
also contribute to the observed variation in BIM durability. Lethal mutations are very273
common and can reach up to 40% of viruses total mutations [37, 38, 39], but, to our274
knowledge, the heterogeneity of the probability of lethal mutation along the genome275
has not been studied. Because some genes are known to be essential while others are276
accessory (e.g. orf39 and orf41 are not expressed during an infection by phage 2972 [35]),277
we can expect that mutations in different genes should result in different fractions of278
lethal mutations and, consequently, in variations in the durability among BIMs targeting279
these different genes.280
281
Additional experiments are required to evaluate the relative importance of the varia-282
tions in (i) mutation rate and (ii) the proportion of lethals along the phage genome on283
the durability of CRISPR resistance. The heterogeneity in the mutation rate could be284
assessed by measuring the durability of several spacers that target different non-functional285
coding regions of the phage genome. Phage 2972 carry such a sequence in the form286
of an incomplete lysogeny module that is not expressed [26, 35]. If we could create287
different BIMs targeting this module, any heterogeneity in durability among those BIMs288
would only result from an heterogeneity in the mutation rates among the different target289
sequences. To evaluate the alternative hypothesis that the variation in durability results290
from variation in the fraction of lethal mutants, one could measure directly this fraction291
of lethal mutants through the systematic introduction of point mutations in the target292
sequence of BIMs with contrasted levels of durability [37, 38, 39]. Thanks to recent293
progress in molecular biology, a range of mutants can be produced by systematically294
changing each of the nucleotide of the target sequence [40, 41]. The comparison of the295
number of lethal mutations for a durable and non-durable resistance would allow one to296
evaluate directly the impact of this factor on the variation of the durability.297
298
CRISPR–Cas immunity is known to generate and maintain a high diversity of resistance299
alleles against the same phage [22, 42] and this diversity in resistance is known to limit300
the growth of the phage population [28, 42]. Theoretical models and experimental tests301
9
indicate that such diversity limits the evolutionary emergence of the pathogens [28]. Yet,302
those studies ignore the heterogeneity in the durability of resistance among different303
alleles. Our results indicate that another potential benefit of generating this diversity is304
to explore a range of durability of resistance. The most durable alleles will outcompete305
the other BIMs and this may provide a very robust way to hamper the evolution of the306
phage. In addition to this inter-host diversity, a single cell can acquire more than one307
spacer against the same parasite. The acquisition of multiple spacers targeting different308
parts of the phage genome implies that the phage needs multiple mutations before it309
can infect this multiply resistant bacteria [43]. As most escape mutations are costly310
(Figure 2), carrying multiple escape mutations is likely to reduce dramatically the fitness311
of the phage. In contrast, the acquisition of multiple spacers does not alter the fitness312
of the bacteria [44]. This asymmetry may help explaining the ultimate extinction of313
phage populations coevolving with CRISPR–Cas immunity [22, 45]. It is also impor-314
tant to note that some phages have evolved the ability to defeat CRISPR immunity315
using anti-CRISPR proteins that inhibit the defense conferred by CRISPR–Cas [46, 47]316
(note that to our knowledge, phage 2972 does not carry any anti-CRISPR against S.317
thermophilus CRISPR systems). Even though anti-CRISPR can be partially efficient318
against CRISPR–Cas, the cooperation between phages ensures that, above a minimal319
concentration, phages can invade a resistant host population without acquiring escape320
mutations in the sequences targeted by CRISPR–Cas [48, 49].321
322
S. thermophilus is widely used by the dairy industry for the manufacture of several323
fermented milk products (yoghurt, cheese) and the identification of BIMs with particularly324
durable resistance could have very practical implications. The use and/or the combination325
of these BIMs is likely to protect the starter cultures against phage infection. In addition,326
it would be particularly useful to identify durable spacers that target related phages.327
Such generalist spacers have been observed before [23]. The use of a durable generalist328
spacer could massively improve the resistance of S. thermophilus strains. Our biological329
model provides also a unique opportunity to evaluate experimentally the effectiveness of330
different intervention strategies on the long-term efficacy of resistance to pathogens. It331
may thus provide important insights for the implementation of sustainable management332
of pathogens and pests [4, 9, 28].333
334
In addition to these applications in the dairy industry and in agriculture, the CRISPR-335
Cas9 technology can be used as a driving endonuclease, ie. a genetic tool that make336
an engineered allele spread into natural populations by non-mendalian heredity [50].337
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Indeed, in a heterozygote carrying a CRISPR-Cas9 and its guide, the endonuclease will338
target and cleave the homologous allele. As repair mechanism usually involve homologous339
DNA sequences, they will usually add a copy of the CRISPR-Cas9 and its guide at the340
place of the former allele, leading to the rapid spread of the CRISPR-Cas9/guide in341
the population[50, 51]. However, if the presence of CRISPR-Cas9 is costly for its host,342
it is likely that escape mutation will emerge and break the spread of the gene-drive343
[51, 52]. Our results indicate that the durability of gene-drive strategies targeting distinct344
genome regions is likely to be very variable. Understanding the ultimate source of the345
variation of durability is particularly important for the effectiveness of gene-drive based346
on CRISPR-Cas9.347
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Figure 1: Variability in the durability of CRISPR–Cas immunity.
The mutation rate of 17 protospacers whose positions are labelled on the x-axis
were measured using fluctuation tests. PE values, ie. the number of replicates
in which a phage escape mutant evolved, are reported and show heterogeneity
among the targeted sequences, implying that there is heterogeneity in the
durability of CRISPR–Cas resistances. The two protospacers of orf 37 have the
same mutation rate but at least one of the protospacer of orf 38 has a lower
mutation rate.
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Figure 2: Distribution of fitness effects of escape mutations in the phage.
Relative fitness was measured through competition experiments with a collection
of 40 escape phages, mutated on their seed or PAM sequences. Phages that
carry a neutral and deleterious mutations are represented in medium and dark
grey respectively. Black dots show the relative fitness of each escape phage.
The dotted segment represents the fitness of WT phage 2972. Fitness value of
each escape phage is also provided in the supplementary informations K.
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Figure 3: Relative fitness of phage escape mutants against durability (proba-
bility of escape PE) of their respective BIM.
Each color corresponds to a single BIM and each dot to a single escape phage.
Error bars correspond to 95% Confidence Intervals. Raw data are provided in
supplementary informations I and K.
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Supplementary informations521
A. Primers used for CRISPR PCR and sequencing522
A.1. PCR Protocol523
The PCR mix contained 5 µL of Multiplex Qiagen, 1 µL of each primer, 2 µL of sterile524
water and 1 µL of 1% bacteria. The PCR program involves 15 minutes at 94◦C, 35 cycles525
of 30 seconds at 94◦C, 90 seconds at 60◦C (CRISPR1 and 2) or 56◦C (CRISPR3 and 4),526
1 minute at 72◦C and ended by 10 minutes at 60◦C.527
A.2. Primers528
Table S1: Primer sequences used for the PCR of S. thermophilus loci.
CRISPR Forward Primer (5’-3’) Reverse primer (5’-3’)
1 TGCTGAGACAACCTAGTCTCTC GGATCCGGATCCGTTGAGGCCTTGTTC
2 GCCCCTACCATAGTGCTGAAAAATTAG CCAAATCTTGTGCAGGATGGTCG
3 GGTGACAGTCACATCTTGTCTAAAACG GCTGGATATTCGTATAACATGTC
4 CCTCATAGAGCTTTGAAAGATGCTAGAC GTTCTTCTTGATGCTTGTCGAGGC
19
B. Characterization of BIMs529
Table S2: BIMs spacer sequence and protospacer position in 2972 phage genome.
BIMs are named with the following nomenclature: NC or ORF indicates if the
BIM targets a non-coding or a coding sequence respectively. When appropriate,
the number following the _ sign indicates the targeted orf. If multiple BIMs
target the same orf, they are distinguished by capital letters.
Name Spacer sequence (5’-3’) Protospacer
position in
the phage
genome
orf targeted
in the phage
genome
NC AGGAGGTGGACATATTGGGCTAAATCAACG 954 – 983 non-coding
ORF_2 GCTCTACGACTTCTTCCACGAGTTCCTGCC 1 199 – 1
228
2
ORF_5 CCATCTCGTTGTCCTTACGACGACCAGACT 3 223 – 3
252
5
ORF_9 AGATATTGATTATGGTGTTAAAGCAGACCA 7 020 – 7
049
9
ORF_17 AAGCAAGTTGATATATTTCTCTTTCTTTAT 10 270 – 10
299
17
ORF_19 TTATCTGATTTTTTCCCCTTGATTTCGGGG 16 226 – 16
255
19
ORF_20 TAAGGCAAACGAGACCGAGAGAGCTGCAGC 21 022 – 21
051
20
ORF_21 TTGACGATTGGGAACCGTGGAAGGAATTTG 23 067 – 23
096
21
ORF_24 AACACAGATGTTTTAGACCATGCGCAGAAG 24 326 – 24
355
24 + non-
coding
ORF_27 TATTTGTACGTGAGTGGAAGTGCTTAGACT 25 544 – 25
473
27 + non-
coding
ORF_33 TTTCATCGTCAATTTCCATGTTATAAATCT 27 003 – 27
032
33
ORF_37_A TCGTTTTCAGTCATTGGTGGTTTGTCAGCG 29 988 – 30
017
37
Continued on next page.
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Name Spacer sequence (5’-3’) Protospacer
position in
the phage
genome
orf targeted
in the phage
genome
ORF_37_B AGAAGCACCTCTTGCGTTGATAAAAGTATT 30 369 – 30
398
37
ORF_38_A ATATTCATATTCCCTGCTCATGTTTGATAG 31 055 – 31
084
38
ORF_38_B CTTTATACTCGTTAAGAATGGCATCTACGA 31 132 – 31
161
38
ORF_38_C CACATATCGACGTATCGTGATTATCCCATT 31 709 – 31
737
38
ORF_44 AGCCTAGATAGCGAAGTTGATCGTATCTAT 34 587 – 34
616
44
530
21
C. Graphic overview of Luria-Delbrück protocol531
Phage 
amplification
Detection 
of escape 
phages
Tested BIM
Phage 
2972 WT Bacteria
BIM lawn on Petri 
dish
Transfer of 
5µL (1/4)
x 17 (number of tested BIMs)
x 3 (number of independent 
phage 2972 lysates)
Escape phage 
amplification
Stamping 
of 5 µL
532
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D. Impact of centrifugation on phage titre in lysate533
Table S3: Impact of centrifugation on phage titre. Centrifugation does not
modify phage titre.
Titre before centrifugation (PFU/mL) Titre after centrifugation (PFU/mL)
8.2× 108 5.6× 108
1.0× 109 7.8× 108
1.2× 109 6.6× 108
9.2× 108 9.2× 108
W=14.5, p-value=0.081 : No statistical differences in phage titer before and after534
centrifugation.535
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E. Primers used for escape phages sequencing536
Table S4: Primers used for sequencing escape phages.
Phages are named with the following nomenclature: 2972 indicates that it is a
phage derived from 2972 phage; NC or ORF indicates whether the protospacer
is part of a non-coding or a coding sequence respectively. When appropriate,
the number following the _ sign indicates the orf in which the protospacer is
located. If a given orf contains several protospacers, they are distinguished by
a capital letter.
Phage Left Primer Right Primer
2972_NC TAGCGGAATTTTCACGGTCT CCTGTAGCGGCATTTAGCTC
2972_ORF_2 CTTGCTTAGCCGTTGGGTAG GGCTCATTTGTGGGTTGTCT
2972_ORF_5 CGGATAGGATTGCCAGCTAA GTCATCGGTAGCACAGAGCA
2972_ORF_9 AAAACGACCGTCAACAGCTT GTAGATGCAGCCTTGCGAAT
2972_ORF_17 AGAGCGCTAGACATGCCATT AGAGGCGACCGAGTAAGTGA
2972_ORF_19 TCAGAGCCTTGCACAACATC GCGGCACTTTCTTGTATGGT
2972_ORF_20 AGAGATGGAAGCCAAAGCAA AAGATCCCGTTCTCGATGTG
2972_ORF_21 ATGGAAAGCCTAGCGTTGAA TGTGGCTAGCTCCTTCGTTT
2972_ORF_24 TCGGATTGCTACCGAAAATC CAATCTGCTCCACTGCGTTA
2972_ORF_27 AATACCGTGCCAAGTCTGGT GGGATCCCATTTTCTCATTACT
2972_ORF_33 AATGTCTGCCTCAAGCGACT GTGTGCGGAGTGCAACTAAA
2972_ORF_37_A CTTGCATGTTCCCAATTCCT ACCGATATCCCACTTCCAGA
2972_ORF_37_B AAGGAATTGGGAACATGCAA ACTCGGCTAGGGCGTTATTT
2972_ORF_38_A TCCCATCCGTTTATGGTAGG ACCCTCGAAAATGGGAAAGT
2972_ORF_38_B ACCCTCGAAAATGGGAAAGT TCCCATCCGTTTATGGTAGG
2972_ORF_38_C TTGCCATTATCGAAGGGAAG CGAGTGGAAACGACATCTGA
2972_ORF_44 TCGCAAGGAAATCCAAGAGT CGTTTAACACTTTCCTTTTCAAGA
24
F. Sequences of escape phages protospacer537
Table S5: Sequences of escape phages protospacer and PAM. Mutations are highlighted
in grey and their PAM is framed. WT and lower case letters indicate if the
sequence corresponds to the WT phage 2972 or an escape mutant.
Phage escape mutants Protospacer +
  PAM
2972_NC_WT AGGAGGTGGACATATTGGGCTAAATCAACGAC
  AGAA
2972_NC_a AGGAGGTGGACATATTGGGCTAAATCGACGAC
  AGAA
2972_NC_c AGGAGGTGGACATATTGGGCTAAATCAACGAC
  AGAG
2972_NC_d AGGAGGTGGACATATTGGGCTAAACCAACGAC
  AGAA
2972_NC_e AGGAGGTGGACATATTGGGCTAAATCACCGAC
  AGAA
2972_ORF_2_WT GCTCTACGACTTCTTCCACGAGTTCCTGCCTC
  AGAA
2972_ORF_2_a GCTCTACGACTTCTTCCACGAGTTCCTGCCTC
  ATAA
2972_ORF_2_b GCTCTACGACTTCTTCCACGAGTTCCTGCCTC
  AAAA
2972_ORF_2_c GCTCTACGACTTCTTCCACGAGTTCCTTCCTC
  AGAA
2972_ORF_5_WT CCATCTCGTTGTCCTTACGACGACCAGACTTG
  AGAA
2972_ORF_5_a CCATCTCGTTGTCCTTACGACGACCATACTTG
  AGAA
2972_ORF_9_WT AGATATTGATTATGGTGTTAAAGCAGACCATA
  AGAA
2972_ORF_9_a AGATATTGATTATGGTGTTAAAGCAGAGCATA
  AGAA
2972_ORF_9_b AGATATTGATTATGGTGTTAAAGCAGAAAATA
  AGAA
2972_ORF_17_WT AAGCAAGTTGATATATTTCTCTTTCTTTATTA
  AGAA
2972_ORF_17_a AAGCAAGTTGATATATTTCTCTTTCTTTATTA
  AGAG
2972_ORF_17_b AAGCAAGTTGATATATTTCTCTTTCTTTGTTA
  AGAA
2972_ORF_17_d AAGCAAGTTGATATATTTCTCTTTCTTTATTA
  ATAA
2972_ORF_19_WT TTATCTGATTTTTTCCCCTTGATTTCGGGGAT
  AGAA
2972_ORF_19_a TTATCTGATTTTTTCCCCTTGATTTCGCGGAT
  AGAA
2972_ORF_19_b TTATCTGATTTTTTCCCCTTGATTTCTTGGAT
  AGAA
2972_ORF_20_WT TAAGGCAAACGAGACCGAGAGAGCTGCAGCCG
  AGAA
2972_ORF_20_b TAAGGCAAACGAGACCGAGAGAGCTGCAGCCG
  AGAC
2972_ORF_21_WT TTGACGATTGGGAACCGTGGAAGGAATTTGCA
  AGAA
2972_ORF_21_a TTGACGATTGGGAACCGTGGAAGGAATTTGCA
  AGAC
2972_ORF_21_c TTGACGATTGGGAACCGTGGAAGGAATTTGCA
  AGTA
2972_ORF_21_d TTGACGATTGGGAACCGTGGAAGGAATTTGCA
  AAAA
Continued on next page.
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Phage escape mutants Protospacer +
  PAM
2972_ORF_24_WT AACACAGATGTTTTAGACCATGCGCAGAAGGG
  AGAA
2972_ORF_24_c AACACAGATGTTTTAGACCATGCGCAGA-GGG
  AGAA
2972_ORF_27_WT TATTTGTACGTGAGTGGAAGTGCTTAGACTTT
  AGAA
2972_ORF_27_a TATTTGTACGTGAGTGGAAGTGCTTAGACTTT
  AAAA
2972_ORF_27_d TATTTGTACGTGAGTGGAAGTGCTTAGTCTTT
  AGAA
2972_ORF_33_WT TTTCATCGTCAATTTCCATGTTATAAATCTCT
  AGAA
2972_ORF_33_a TTTCATCGTCAATTTCCATGTTATAAATCTCT
  AAAA
2972_ORF_33_b TTTCATCGTCAATTTCCATGTTATAAATCTCT
  TGAA
2972_ORF_33_c TTTCATCGTCAATTTCCATGTTATAAATTTCT
  AAAA
2972_ORF_37_A_WT TCGTTTTCAGTCATTGGTGGTTTGTCAGCGAA
  AGAA
2972_ORF_37_A_a TCGTTTTCAGTCATTGGTGGTTTGTCAGCGAA
  AGAG
2972_ORF_37_B_WT AGAAGCACCTCTTGCGTTGATAAAAGTATTGC
  AGAA
2972_ORF_37_B_a AGAAGCACCTCTTGCGTTGATAAAAGTTTTGC
  AGAA
2972_ORF_37_B_b AGAAGCACCTCTTGCGTTGATAAAAGCATTGC
  AGAA
2972_ORF_37_B_c AGAAGCACCTCTTGCGTTGATAAAAGTATTGC
  AAAA
2972_ORF_37_B_d AGAAGCACCTCTTGCGTTGATAAAATTATTGC
  AGAA
2972_ORF_38_A_WT ATATTCATATTCCCTGCTCATGTTTGATAGCA
  AGAA
2972_ORF_38_A_a ATATTCATATTCCCTGCTCATGTTTGAAAGCA
  AGAA
2972_ORF_38_A_b ATATTCATATTCCCTGCTCATGTTTGTTAGCA
  AGAA
2972_ORF_38_A_e ATATTCATATTCCCTGCTCATGTTCGATAGCA
  AGAA
2972_ORF_38_B_WT CTTTATACTCGTTAAGAATGGCATCTACGACA
  AGAA
2972_ORF_38_B_a CTTTATACTCGTTAAGAATGGCATCTTCGACA
  AGAA
2972_ORF_38_B_c CTTTATACTCGTTAAGAATGGCATCTACGACA
  ATAA
2972_ORF_38_C_WT ACATATCGACGTATCGTGATTATCCCATTCA
  AGAA
2972_ORF_38_C_a ACATATCGACGTATCGTGATTATACAATTCA
  AGAA
2972_ORF_38_C_b ACATATCGACGTATCGTGATTATCCCATTCA
  TGAA
2972_ORF_38_C_c ACATATCGACGTATCGTGATTATCCCCTTCA
  AGAA
2972_ORF_38_C_e ACATATCGACGTATCGTGATTATGCCATTCA
  AGAA
2972_ORF_44_WT AGCCTAGATAGCGAAGTTGATCGTATCTATTT
  AGAA
2972_ORF_44_b AGCCTAGATAGCGAAGTTGATCGTATCTGTTT
  AGAA
538
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G. Measure of phages fitness: determination of phage539
proportion during the competition experiment540
The qPCR mix was composed of 3 µL of 2X Master Mix, 0.3 µL of primers at 10 µM,541
1.7 µl of water and 1 µl of phages solution at 105 or 106 PFU/mL. To specifically542
target the referee phage (ie the phage with a 37-bp deletion), we used primers 5’-543
TAGACCATGCGCAGAAGGGA–3’ and 5’-CCACGATTTCAACGATACGC-3’. To544
amplify all phages, we used 5’-GAAAATCAGCAGCAAATGGC-3’ and 5’-TGACCA-545
CATCTTCTAAGCCGT-3’. The qPCR program was as follows: an initial denaturation546
at 95◦C for 10 minutes, 45 amplification cycles of 15 seconds at 95◦C, 20 seconds at547
58◦C, 25 seconds at 72◦C. To obtain melting curves, temperature reached 95◦C for 5548
seconds, 60◦C for a minute and rose to 97◦C at a rate of 0.11◦C per second. The DNA549
was cooled down at 40◦C for 30 seconds. Calibration curve was obtained by applying550
this protocol to known-phage ten-times dilutions from 107 PFU/mL to 103 PFU/mL.551
To attribute an absolute number of phages to each qPCR point, these dilutions were552
titrated simultaneously (see above).553
554
In our collection, the Reference phage is targeted by the BIM that target orf24 and555
carries a 37 bp deletion in its protospacer.556
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H. Durability of CRISPR resistances557
Figure S1: Variability in the durability of CRISPR–Cas immunity.
The probability of escape PE was measured for each BIM using fluctuation
tests. Mutation rates of each protospacer can be found in supplementary
information I.
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I. Mutation rate of CRISPR-targeted sequences558
Table S6: Mutation rate and 95% Confidence Intervals of phage protospacers. Mutation
rates were measured using fluctuation tests (see Materials and Methods).
Name Mutation rate 95% Confidence Interval
NC 4.9× 10−8 [3.1× 10−8, 6.7× 10−8]
ORF_2 1.9× 10−7 [6.8× 10−8, 3.1× 10−7]
ORF_5 1.1× 10−6 [8.6× 10−7, 1.3× 10−6]
ORF_9 1.5× 10−7 [2.7× 10−8, 2.8× 10−7]
ORF_17 1.6× 10−7 [4.5× 10−8, 2.8× 10−7]
ORF_19 1.2× 10−6 [6.2× 10−7, 1.7× 10−6]
ORF_20 6× 10−7 [2.5× 10−7, 9.5× 10−7]
ORF_21 5.7× 10−8 [2.1× 10−8, 9.2× 10−8]
ORF_24 4.6× 10−8 [1.0× 10−8, 8.2× 10−8]
ORF_27 4.3× 10−7 [2.2× 10−7, 6.5× 10−7]
ORF_33 4.8× 10−8 [4.6× 10−9, 9.2× 10−8]
ORF_37_A 7.1× 10−7 [2.9× 10−7, 1.1× 10−6]
ORF_37_B 5.1× 10−7 [1.6× 10−7, 8.6× 10−7]
ORF_38_A 1.3× 10−7 [6.5× 10−8, 1.9× 10−7]
ORF_38_B 2.1× 10−7 [9.3× 10−8, 1.3× 10−7]
ORF_38_C 9.4× 10−9 [−1.2× 10−9, 2.0× 10−8]
ORF_44 2.5× 10−7 [5.2× 10−8, 4.4× 10−7]
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J. Mutation profile of escape phages559
Table S7: Profile of substitutions carried by phage escape mutants. 27 substitutions are
transversions and 16 are transitions.
Type of substitution Substitution Number of occurences
Purine Transition
A → G 6
G → A 6
Pyrimidine Transition
C → T 1
T → C 3
Transversion
A → C 4
C → A 4
A → T 7
T → A 1
T → G 0
G → T 8
G → C 1
C → G 2
30
K. Escape phage relative fitness560
561
Table S8: Relative fitness of escape phages. Deleterious mutations are highlighted in
dark grey and neutral mutation in medium grey.
Phage escape mutants Relative Fitness
2972_NC_a 0.688
2972_NC_c -2.135
2972_NC_d -2.072
2972_NC_e -2.590
2972_ORF_2_a -3.086
2972_ORF_2_b -1.573
2972_ORF_2_c -0.754
2972_ORF_5_a -5.005
2972_ORF_9_a -1.134
2972_ORF_9_b -1.056
2972_ORF_17_a -1.462
2972_ORF_17_b -3.013
2972_ORF_17_d -3.864
2972_ORF_19_a -2.424
2972_ORF_19_b -4.333
2972_ORF_20_b -2.959
2972_ORF_21_a -4.134
2972_ORF_21_c -4.431
2972_ORF_21_d -2.401
2972_ORF_24_c -3.074
2972_ORF_27_a -0.093
2972_ORF_27_d -0.890
2972_ORF_33_a -2.861
2972_ORF_33_b -0.426
2972_ORF_33_c -0.657
2972_ORF_37_A_a -0.840
2972_ORF_37_B_a -5.290
2972_ORF_37_B_b 0.458
Continued on next page.
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Phage escape mutants Relative Fitness
2972_ORF_37_B_c -2.365
2972_ORF_37_B_d -1.940
2972_ORF_38_A_a -4.355
2972_ORF_38_A_b -1.311
2972_ORF_38_A_e -1.652
2972_ORF_38_B_a 0.415
2972_ORF_38_B_c -4.282
2972_ORF_38_C_a -3.166
2972_ORF_38_C_b -6.212
2972_ORF_38_C_c -2.674
2972_ORF_38_C_e -0.215
2972_ORF_44_b 0.150
562
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L. Impact of synonymous mutations on the fitness of phage563
escape mutants564
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Figure S2: Distribution of fitness effects of synonymous escape mutations in
the phage.
Relative fitness was measured through competition experiments with a collec-
tion of 10 escape phages with a synonymous mutation on their seed or PAM
sequences. Phages that carry a neutral and deleterious mutations are repre-
sented in medium and dark grey respectively. Black dots show the relative
fitness of each escape phage. The dotted segment represents the fitness of
WT phage 2972. Fitness value of each escape phage is also provided in the
supplementary informations K.
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